Clinical Trial Update: Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating HuCNS-SC human central nervous system stem cells for thoracic spinal cord injury, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• HuCNS-SC

Snippet

Sponsor: StemCells, Inc. | Conditions: Thoracic Spinal Cord Injury, Spinal Cord Injury | Phase 1, Phase 2 | Status: COMPLETED